US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by Arcus Biosciences

< Previous 1 2 3 4 5 6 Next >
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Host Investor Event Featuring New Data for Casdatifan as a Treatment for Kidney Cancer Across Multiple Lines of Therapy
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Participate in Three Upcoming Investor Conferences
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Second-Quarter 2026 Financial Results and Provides a Pipeline Update
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces Clinical Supply Agreement with AVEO Oncology to Evaluate Casdatifan in Combination with Tivozanib for Advanced Kidney Cancer Patients
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2026 Financial Results and Pipeline Updates
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
New Research Published in Nature Links Clinical Activity with HIF‑2a Biology in Advanced Kidney Cancer Patients Treated with Casdatifan
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces Clinical Trial Collaboration and Supply Agreement to Evaluate Casdatifan in Combination with PD‑L1/VEGF‑A Bispecific Immunomodulator to Treat Kidney Cancer
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports First-Quarter 2026 Financial Results and Provides a Pipeline Update
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2026 Financial Results and Pipeline Updates
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2025 Financial Results and Pipeline Updates
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Provides Update on Phase 3 STAR-221 Study and Concentrates Its R&D Investment on Casdatifan and Emerging Inflammation and Immunology Portfolio
From Arcus Biosciences
Via Business Wire
Tickers RCUS
News headline image
Arcus Biosciences Announces New Employment Inducement Grants
From Arcus Biosciences
Via Business Wire
Tickers RCUS
< Previous 1 2 3 4 5 6 Next >